Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
Introduction. Based on clinical studies data voriconazole is recommended as the drug of choice for treatment of invasive aspergillosis (IA) – a widespread infectious complications occurring in immunocompromised patients and is characterized by severe clinical course and high mortality.The aim of thi...
Saved in:
| Main Authors: | V. I. Ignatieva, M. V. Avksentieva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2015-06-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/141 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of voriconazole and caspofungin for the treatment of invasive pulmonary aspergillosis in critically ill patients in China
by: Zhuo Li, et al.
Published: (2025-05-01) -
The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review
by: Yan Chen, et al.
Published: (2025-01-01) -
Outcome Analysis of Breakthrough Invasive Aspergillosis on Anti-Mold Azole Prophylaxis and Treatment: 30-Year Experience in Hematologic Malignancy Patients
by: Hiba Dagher, et al.
Published: (2025-02-01) -
Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis
by: Charul Singh, et al.
Published: (2025-07-01) -
Antifungal Activity of Voriconazole on Local Isolates an In-vitro Study
by: Karina Q. De Sagun-Bella, MD, et al.
Published: (2013-06-01)